HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).

Abstract
Flow cytometry is commonly used to establish the diagnosis of chronic lymphocytic leukemia (CLL). A defined combination of antibodies discriminates between normal B cells and CLL cells (coexpression of CD5, CD19, and CD23). The receptor tyrosine-like orphan receptor one (ROR1) is an embryonic glycoprotein involved in several developmental processes. It was shown to be highly and specifically expressed on circulating B lymphoma cells, but not on normal B cells. Here, we examined the potential of ROR1 as a diagnostic marker in initial and follow-up diagnostics of patients with CLL. 105 untreated and 72 treated patients, as well as healthy volunteers were examined using flow cytometry assays. Furthermore, we examined 10 patients with various B cell non-Hodgkin lymphomas (B-NHL). ROR1 was detected using a directly labeled antibody. We detected uniformly high ROR1 expression levels in all CLL samples. In marked contrast, only low or absent ROR1 expression levels were found on B cells from healthy donors. ROR1 expression in CLL patients was not influenced by various treatments. Taken together, ROR1 may be used as a diagnostic marker for CLL. As it is the only antigen which can exclusively be detected on neoplastic B cells it may greatly increase both, specificity as well as sensitivity, in lymphoma diagnostics.
AuthorsSabrina Uhrmacher, Christina Schmidt, Felix Erdfelder, Simon Jonas Poll-Wolbeck, Iris Gehrke, Michael Hallek, Karl-Anton Kreuzer
JournalLeukemia research (Leuk Res) Vol. 35 Issue 10 Pg. 1360-6 (Oct 2011) ISSN: 1873-5835 [Electronic] England
PMID21531460 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies
  • Antigens, CD
  • Biomarkers
  • ROR1 protein, human
  • Receptor Tyrosine Kinase-like Orphan Receptors
Topics
  • Aged
  • Aged, 80 and over
  • Antibodies (analysis)
  • Antigens, CD (immunology, metabolism)
  • B-Lymphocytes (metabolism, pathology)
  • Biomarkers (analysis)
  • Case-Control Studies
  • Female
  • Flow Cytometry
  • Follow-Up Studies
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell (diagnosis, immunology, metabolism, pathology)
  • Lymphoma, B-Cell (diagnosis, immunology, metabolism, pathology)
  • Male
  • Middle Aged
  • Receptor Tyrosine Kinase-like Orphan Receptors (analysis, biosynthesis)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: